UY26964A1 - DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE - Google Patents
DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCEInfo
- Publication number
- UY26964A1 UY26964A1 UY26964A UY26964A UY26964A1 UY 26964 A1 UY26964 A1 UY 26964A1 UY 26964 A UY26964 A UY 26964A UY 26964 A UY26964 A UY 26964A UY 26964 A1 UY26964 A1 UY 26964A1
- Authority
- UY
- Uruguay
- Prior art keywords
- erythromycin
- derivatives
- replaced
- gastrointestinal tolerance
- greater gastrointestinal
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Compuestos de fórmula I son útiles para el tratamiento de infeciones bacterianas pero sin producir el efecto colateral de intolerancia gastrointestinal. También se revelan composiciones que contienen los compuestos y métodos de tratamiento que los utilizan.Compounds of formula I are useful for the treatment of bacterial infections but without producing the side effect of gastrointestinal intolerance. Compositions containing the compounds and methods of treatment that use them are also disclosed.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24077700P | 2000-10-16 | 2000-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY26964A1 true UY26964A1 (en) | 2002-06-20 |
Family
ID=22907903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY26964A UY26964A1 (en) | 2000-10-16 | 2001-10-12 | DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1328534A2 (en) |
| JP (1) | JP2004529857A (en) |
| AU (1) | AU2002213267A1 (en) |
| BR (1) | BR0109946A (en) |
| CA (1) | CA2420012A1 (en) |
| MX (1) | MXPA03003311A (en) |
| PE (1) | PE20020522A1 (en) |
| UY (1) | UY26964A1 (en) |
| WO (1) | WO2002032919A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2004117082A (en) | 2001-12-05 | 2005-04-10 | Орто-Макнейл Фармасьютикал, Инк. (Us) | KETOLIDE 6-0-ACYL DERIVATIVES OF ERYTHROMYCIN AS ANTIBACTERIAL MEANS |
| EP1501845A1 (en) * | 2002-04-30 | 2005-02-02 | Abbott Laboratories | Antibacterial compounds with improved pharmacokinetic profiles |
| US6727229B2 (en) * | 2002-08-19 | 2004-04-27 | Enanta Pharmaceuticals, Inc. | 11,12-substituted lactone ketolide derivatives having antibacterial activity |
| WO2004078771A1 (en) * | 2003-03-07 | 2004-09-16 | Taisho Pharmaceutical Co., Ltd. | 2-fluoro-6-o-substituted ketolide derivative |
| JP2007223900A (en) * | 2004-02-03 | 2007-09-06 | Taisho Pharmaceut Co Ltd | 6-O-substituted ketolide derivatives |
| JP2007254285A (en) * | 2004-03-16 | 2007-10-04 | Taisho Pharmaceut Co Ltd | 2-Fluoro-6-O-substituted ketolide derivatives |
| EP1985620A4 (en) | 2006-02-07 | 2012-08-15 | Taisho Pharmaceutical Co Ltd | 10a-azalide compound |
| US8293715B2 (en) | 2007-08-06 | 2012-10-23 | Taisho Pharmaceutical Co., Ltd. | 10a-Azalide compound crosslinked at 10a- and 12-positions |
| US8299035B2 (en) | 2008-05-15 | 2012-10-30 | Taisho Pharmaceutucal Co., Ltd. | 10a-azalide compound having 4-membered ring structure |
| CN102234302B (en) * | 2010-05-07 | 2014-05-07 | 北京理工大学 | Novel ketolide derivatives, and preparation method and medicinal compositions thereof |
| AR085286A1 (en) | 2011-02-21 | 2013-09-18 | Taisho Pharmaceutical Co Ltd | MACROLIDO DERIVATIVE REPLACED IN POSITION C-4 |
| AR102810A1 (en) | 2014-08-18 | 2017-03-29 | Taisho Pharmaceutical Co Ltd | MACROLID DERIVATIVE REPLACED IN POSITION C-4 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6054435A (en) * | 1999-03-19 | 2000-04-25 | Abbott Laboratories | 6-O-substituted macrolides having antibacterial activity |
-
2001
- 2001-10-12 UY UY26964A patent/UY26964A1/en not_active Application Discontinuation
- 2001-10-15 PE PE2001001021A patent/PE20020522A1/en not_active Application Discontinuation
- 2001-10-16 AU AU2002213267A patent/AU2002213267A1/en not_active Abandoned
- 2001-10-16 JP JP2002536300A patent/JP2004529857A/en not_active Withdrawn
- 2001-10-16 MX MXPA03003311A patent/MXPA03003311A/en unknown
- 2001-10-16 BR BR0109946-9A patent/BR0109946A/en not_active Application Discontinuation
- 2001-10-16 WO PCT/US2001/032278 patent/WO2002032919A2/en not_active Ceased
- 2001-10-16 CA CA002420012A patent/CA2420012A1/en not_active Abandoned
- 2001-10-16 EP EP01981637A patent/EP1328534A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BR0109946A (en) | 2005-08-02 |
| EP1328534A2 (en) | 2003-07-23 |
| CA2420012A1 (en) | 2002-04-25 |
| JP2004529857A (en) | 2004-09-30 |
| PE20020522A1 (en) | 2002-06-25 |
| MXPA03003311A (en) | 2003-09-10 |
| WO2002032919A3 (en) | 2002-09-19 |
| WO2002032919A2 (en) | 2002-04-25 |
| AU2002213267A1 (en) | 2002-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP003699A (en) | FAB I INHIBITORS | |
| DE60131138D1 (en) | ANTIBACTERIAL AGENTS | |
| NO20025954D0 (en) | Glykopeptidfosfonatderivater | |
| PA8527001A1 (en) | USEFUL POLYARILCARBOXAMIDS AS LIPID REDUCING AGENTS | |
| UY26964A1 (en) | DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE | |
| DE60135919D1 (en) | FARNESYL TRANSFERASE-INHIBITING 6-HETEROCYCLYLMETHYL-CHINOLINE AND CHINAZOLE DERIVATIVES | |
| CY1107789T1 (en) | ANTHELMINTHICAL COMPOSITIONS CONTAINING ABMERTEIN OR MILBEMYKIN COMPOSITIONS AFTER DISCOVERY COMPOUNDS | |
| ATE433963T1 (en) | FAB-I INHIBITORS | |
| DE60121345D1 (en) | ALKYLATED IMIDAZOPYRIDINE DERIVATIVES | |
| DK1313740T3 (en) | Prodrugs of imidazopyridine derivatives | |
| DE60127131D1 (en) | TRICYCLIC IMIDAZOPYRIDINE | |
| SE9903290D0 (en) | Novel compounds | |
| IS8334A (en) | Antineoplastic compositions consisting of defibrotide single or mixed with other antineoplastic agents | |
| BRPI0412446A (en) | silicon compounds and their use | |
| DE69936052D1 (en) | N1 MODIFIED GLYCOPEPTIDE | |
| DE60304360D1 (en) | N-ARYL-2-OXAZOLIDINONE AND DERIVATIVES | |
| BRPI0415038A (en) | imidazo (4,5-b) pyridine derivatives as non-synthase inhibitors that can be induced | |
| PA8486101A1 (en) | HYGROMYCIN DERIVATIVES | |
| CY1110139T1 (en) | GLYPOPEIDIC ANTIBODIES | |
| ATE425984T1 (en) | TRICYCLIC ANTIBACTERIAL MACROLIDE DERIVATIVES | |
| ATE478155T1 (en) | GLYCOPEPTIDE ANTIBIOTIC | |
| AR023780A1 (en) | CETOLID ANTIBACTERIALS | |
| ECSP003536A (en) | RUFOMYCIN DERIVATIVES USEFUL AS ANTIBIOTICS | |
| ECSP993176A (en) | NEW ANTIBACTERIAL COMPOUNDS AND COMPOSITIONS | |
| PE64099A1 (en) | CEPHALOSPORIN-DERIVED ANTIBIOTIC |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150126 |